REPOSE-XL, NCT04865679: Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends |
|
|
| Recruiting | N/A | 15 | US | Axoguard Nerve Cap® | Axogen Corporation | Symptomatic Neuroma, Amputation, Chronic Nerve Pain | 12/26 | 12/26 | | |
REPOSE-XL, NCT04865679: Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends |
|
|
| Recruiting | N/A | 15 | US | Axoguard Nerve Cap® | Axogen Corporation | Symptomatic Neuroma, Amputation, Chronic Nerve Pain | 12/26 | 12/26 | | |
RANGER, NCT01526681: Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction |
|
|
| Recruiting | N/A | 5000 | Europe, Canada, US | Processed Human Nerve Graft, Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc., Autogenous Nerve Graft, Nerve Tube Conduit, Autologous Breast Reconstruction with Neurotization, Autologous Breast Reconstruction without Neurotization | Axogen Corporation | Peripheral Nerve Injuries | 12/25 | 12/25 | | |
